FDA.reportPublic FDA data

Apolipoprotein A-I (Apo A1) IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of apolipoprotein A-I (Apo A1) lipid in a clinical specimen.
GUDID devices
3
Last updated
2020-04-29 04:47:15

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
10758750001378VITROSORTHO-CLINICAL DIAGNOSTICS, INC.68017692020-04-18
10758750001385VITROSORTHO-CLINICAL DIAGNOSTICS, INC.68017702020-04-18
00859110005869ValidateLgc Clinical Diagnostics, Inc.507ro2020-03-02